
LeftvsLeft RCT
@leftvsleft
@PCORI funded clinical trial | co-PIs @MihailChelu & @KennethEllenbo1 | News and updates on Left vs Left RCT
ID: 1548705677660397568
17-07-2022 16:27:01
80 Tweet
277 Takipçi
259 Takip Edilen

CIED LBCTs kicking off with @hisdoc1 talking about LBBAP vs LV lead, retrospective/observational. This seems to be the data we've been waiting for, pending RCT LeftvsLeft RCT. #HRS2023 #2023PaceSetter ✅Inclusion: EF </=35%, pacing modality per operator ✅N=1778, 981 BiV, 797 LBBAP


My first proud accomplishment at BCM Cardiology BCM Cardiology -- a unified and structurally organized EP sub-section: - 8 full-time faculty performing state-of-the-art procedures at 3 hospitals - Research portfolio in excess of $30M - Looking to grow: recruiting physician-scientists



Our Latest publication on CSP by @MeiburgRoel er al. Comparison of novel ventricular pacing strategies using an electro-mechanical simulation platform academic.oup.com/europace/artic… Europace Editor-in-Chief Dominik Linz LeftvsLeft RCT Margarida Pujol Lopez Jacqueline Joza Haran Burri CARIM

Left vs. Left conference in New Orleans! We are so lucky to have such a wonderful team 🫀 #NOLAleftvsleft #PCORI #LeftvsLeft #cardiology #electrophysiology Mihail G. Chelu, MD, PhD Kenneth Ellenbogen @KendraSmithPhD The Patient-Centered Outcomes Research Institute




Reduction in all-cause mortality for CSP vs BiVP in meta-analysis of observational studies. doi.org/10.1111/jce.15… Alex Kim, Erica Kim Pugal Vijayaraman Kenneth Ellenbogen Will we observe the same in RCTs? Need to do meta-analysis of multiple RCTs? LeftvsLeft RCT #EPeeps comments?


Congratulations to Dr. Gaurav A. Upadhyay and The University of Chicago Team for enrolling the 1st participant in The Patient-Centered Outcomes Research Institute LeftvsLeft RCT ! Mihail G. Chelu, MD, PhD Kenneth Ellenbogen John Mandrola, MD Prash Sanders Pugal Vijayaraman Roy Chung Bengt Herweg Parikshit S Sharma, MD, MPH, FACC, FHRS Jacqueline Joza Dan Lustgarten MDPhD Zachary Whinnett BCM Department of Medicine BCM_CVRI




Milestone: We randomized 10% of the LeftvsLeft RCT study participants. Grateful to our patient partners, investigators, and stakeholders for their support! Mihail G. Chelu, MD, PhD Kenneth Ellenbogen The Patient-Centered Outcomes Research Institute